Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, April 20, 2018 · 443,135,451 Articles · 3+ Million Readers

Trifecta Pharmaceuticals USA distributes improved formulation of popular pharmaceutical-grade Ichthammol 20% Ointment

Formulation is the only Ichthammol 20% on the market in the USA today

FORT LAUDERDALE, FL, USA, February 21, 2018 /EINPresswire.com/ -- TRIFECTA PHARMACEUTICALS, a leading developer, manufacturer and distributor of specialty OTC topical ointments, creams and gels, is distributing an improved formulation of its popular drawing salve, Ichthammol 20% Ointment, under its Globe line of products.

The pharmaceutical-grade home remedy is known for its effectiveness as a drawing salve and successful treatment of skin conditions including boils, carbuncles and abscesses, bites, slivers and stings. The ointment is a 20% Ichthammol formulation and is the only Ichthammol 20% on the market in the USA today. The market-leading Ointment has undergone improvements in recent years, including significant work to eliminate the strong odor normally associated with Ichthammol.

Trifecta Pharmaceuticals USA Chief Executive, Mr. Greg Brondou, says, “Ichthammol 20% Ointment spent some time off the market due to lack of supply. We have worked hard to improve the smell of the ointment, and we’re now able to offer our customers a highly effective remedy for skin conditions that is even easier to use. Ichthammol is back!

“We have received nearly 400 five-star reviews for Ichthammol Ointment on Amazon.com; something we’re very proud of. Customer satisfaction is extremely important to us. We also receive phone calls on a daily basis thanking us for bringing Ichthammol 20% Ointment back and for the results that have been attained from the product.”

Trifecta Pharmaceuticals USA receives regular enquiries about where to purchase Globe Ichthammol 20% Ointment from customers who prefer to purchase products directly from their local pharmacist, rather than online. The company encourages all independent pharmacy owners to go to their ANDA NET account or other wholesaler and purchase Globe Ichthammol 20% Ointment in order to supply their local community with this first aid cabinet staple.

Trifecta Pharmaceuticals USA also sets up direct accounts with independent pharmacies. Please contact the company at info@trifecta-pharma.com to set up an account today.

Trifecta Pharmaceuticals’ resident Registered Pharmacist, Mr. Svet Milic, said, “Ichthammol Ointment has been recommended by doctors and pharmacists for decades because it works. It has demonstrated anti-bacterial, anti-inflammatory and anti-fungal properties and is effective in treating common, minor skin conditions including boils, splinters and other irritations, cuts or scrapes.”

Globe Ichthammol 20% Ointment is now available on Amazon.com, ANDA, from your local independent pharmacy, or via healthcare distributors nationwide.

-ENDS-


About Trifecta Pharmaceuticals USA

Trifecta Pharmaceuticals is a leading developer, manufacturer and distributor of specialty over-the-counter (OTC) topical ointments, creams, gels and oral rehydration salts. The company prides itself on delivering the highest standards in quality, value and service to its customers across the United States.

In addition to its US commercial operations, Trifecta Pharmaceuticals works closely with international NGOs, charitable organizations and government agencies as the preferred provider of generic pharmaceuticals, medical supplies and topical applications.

Trifecta Pharmaceuticals products are available at pharmacies, Amazon.com and via healthcare distributors nationwide. For more information, please visit www.trifecta-pharma.com.

Media and product information enquiries

SALES AND MARKETING
Trifecta Pharmaceuticals USA
info@trifecta-pharma.com
1 888 296 9067

MEDIA AND PUBLIC RELATIONS
Catherine Corcoran
Trifecta Pharmaceuticals USA
813 895 4575

Sales and Marketing
Trifecta Pharmaceuticals USA
1 888 296 9067
email us here

Powered by EIN Presswire